{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007448","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.026265+00:00","generated_at":"2026-06-18T04:21:39.172381+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Acasti voluntarily delists from TSX Venture; confirms no SVB/Silvergate exposure","bullets":["Voluntary delisting from TSXV effective March 27, 2023; Nasdaq listing under ACST unaffected.","Company cites low TSXV volume and high dual-listing costs; expects central Nasdaq marketplace to aid liquidity.","Confirms no exposure to Silicon Valley Bank or Silvergate Bank; no deposits held at those institutions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007448","json":"https://secwatch.observer/filing/0000950170-23-007448.json","markdown":"https://secwatch.observer/filing/0000950170-23-007448.md","text":"https://secwatch.observer/filing/0000950170-23-007448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/0000950170-23-007448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/acst-20230313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:21:39.172381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}